top signin

Pin It

interior-banner-mask

.

Press 2021

Nov 30, 2021

Biostage Hires David Green as Chief Executive Officer New CEO Invests $250,000 i...

New CEO Invests $250,000 in Private Placement and is Appointed as Board Chairman   HOLLISTON, Mass., Nov. 30, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a...


Nov 15, 2021

Biostage Reports Q3 2021 Financial Results...

HOLLISTON, Mass., Nov. 15, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™...


Sep 08, 2021

Biostage™ Appoints Jerry He to Board of Directors and Completes Private Placem...

HOLLISTON, Mass., Sept. 8, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing novel organ regeneration technology based its...


Aug 13, 2021

Biostage Reports Q2 2021 Financial Results...

HOLLISTON, Mass., Aug. 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel...


May 24, 2021

Biostage Reports Q1 2021 Financial Results...

HOLLISTON, Mass., May 24, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel...


Apr 13, 2021

Biostage Reports 2020 Financial Results and Appointment of Interim Vice Presiden...

HOLLISTON, Mass., April 13, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company developing next-generation bioengineered esophageal implants, today...


Jan 25, 2021

Biostage Strengthens Board of Directors with Appointment of Herman Sanchez...

HOLLISTON, Mass., Jan. 25, 2021 /PRNewswire/ -- Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants, today announced...